Latest news
Jaguar Health, Inc.: Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1 - FinanzNachrichten.deFinanzNachrichten.de · Wed, 05 Aug 2026 13:02:00 GMTAfter 12 Months, Crofelemer Cut Support Up to 48% in One MVID Patient - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:00 GMT